|
| Exchange Disseminated Time 11/05/2017 15:33:02 | Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2017, inter alia, to transact the following business:
1. To consider and approve standalone and consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2017.
2. To consider recommendation of dividend for the year ended March 31, 2017 subject to the approval of the shareholders at the ensuing Annual General Meeting.
Further, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from May 17, 2017 to May 30, 2017 (both days inclusive). |
|
|